Steve Williamson

Steve brings a proven track record of product and program launches that have shaped markets and helped to drive business growth globally. Steve has over two decades of medical technology industry experience.

Steve is currently the Chief Commercial Officer at Outset Medical. At Outset, he is leading both the commercial and service organizations as the company is transforming the future of home hemodialysis care. Prior to joining Outset, he served as the Worldwide President for the Peripheral Intervention (PI) business unit of BD, joining BD as part of the C.R. Bard acquisition in 2017. In the eight years that Steve ran PI, he created a culture of category leadership, drove significant revenue growth through a robust cadence of innovative product launches, numerous acquisitions and global expansion for the End-Stage Kidney Disease (ESKD), Peripheral Arterial Disease (PAD), and Oncology businesses. Steve joined Bard from Hologic where he was the Senior Vice President and General Manager of the GYN Surgical Products Business.

Steve earned a BS of Business Administration from the University of Massachusetts, Amherst and an MBA from Bentley College.